Gibson Dunn has advised Beusa Investments, LLC. Beusa Investments, LLC has announced the pricing of its upsized offering of $800 million in aggregate principal amount of...
Beusa Investments Announces $800 Million Senior Notes Offering
GardaWorld Secures $300 Million Term Loan Facility Increase
Gibson Dunn has advised JPMorgan Chase Bank, N.A. and the other arrangers. A $300 million increase to GardaWorld’s term loan facility has been executed through the...
GardaWorld Announces $200 Million Senior Notes Offering
Gibson Dunn has represented BofA Securities, Inc. and other initial purchasers. Garda World Security Corporation has completed a private offering of $200 million aggregate principal amount...
SM Energy Completes $894 Million Tender Offer for Outstanding Notes
Gibson Dunn has advised SM Energy Company. SM Energy Company has announced the final results of its cash tender offer to purchase up to $1,000,000,000 aggregate...
Diversified Energy Company Completes $110 Million Secondary Offering of Common Shares
Sidley and Gibson Dunn have advised Diversified Energy Company. Kirkland & Ellis has advised the selling stockholders. Vinson & Elkins has advised Citigroup Global Markets Inc....
XOMA Royalty Agrees to Acquire Generation Bio in Cash and CVR Deal
Gibson, Dunn & Crutcher LLP has advised XOMA Royalty Corporation. Wilmer Cutler Pickering Hale and Dorr LLP has advised Generation Bio. XOMA Royalty Corporation has entered...
XenoTherapeutics and Xeno Acquisition Corp. Acquire Repare Therapeutics
Gibson Dunn and Blake, Cassels & Graydon LLP have advised XOMA Royalty. Cooley LLP and Stikeman Elliott LLP have advised Repare Therapeutics Inc. XenoTherapeutics, Inc. and...
Horace Mann Educators Corporation Completes $300 Million Senior Notes Offering
Gibson Dunn has advised Horace Mann Educators Corporation, and Davis Polk has advised the representatives of the underwriters. Horace Mann Educators Corporation has completed an offering...
Dianthus Therapeutics Closes $288 Million Public Offering of Common Stock and Pre-Funded Warrants
Gibson Dunn and Goodwin Procter has advised Dianthus Therapeutics, Inc., while Cooley has represented the underwriters. Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused on antibody...